Perrigo Company plc (PRGO)
$15.45+2.59%Close
BUYRECOVERY · day 62
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.1B
- Beta
- 0.54
- Div yield
- 8.29%
- P/E (TTM)
- -1.12
- Short % float
- 17.61%
- Days to cover
- 7.3
- SI change
- +7.1%
- 1W
- +6.99%
- 1M
- +13.10%
- vs SPY 1W
- +6.57%
- vs SPY 1M
- +11.04%
Industry peers
FMP comparable companies · ranked by market cap
- SRRKSELLScholar Rock Holding Corporation$5.1BCRISISQ 22$42.20-0.59%
- FOLDAmicus Therapeutics, Inc.$4.5B$14.49
- LIVNSELLLivaNova PLC$4.2BBEARQ 3$75.91+1.15%
- HTFLBUYHeartflow, Inc. Common Stock$4.1BBULLQ 45$47.63+1.65%
- TARSSELLTarsus Pharmaceuticals, Inc.$3.1BBEARQ 24$72.22+1.69%
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.4BRECOVERYQ 27$42.14+0.33%
- HCMBUYHUTCHMED (China) Limited$2.4BRECOVERYQ 5$13.67-2.98%
- BHCSELLBausch Health Companies Inc.$2.3BRECOVERYQ 2$6.04-1.82%
- SGRYSELLSurgery Partners, Inc.$1.8BRECOVERYQ 7$13.64+2.52%
- ATECBUYAlphatec Holdings, Inc.$1.6BRECOVERYQ -0$10.35+5.44%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 4
- GROWTH
- 45
- GARP
- 49
- TYPE
- Dividend Compounder
Composite of Value · Growth · GARP
ROIC-33.6%
REV YoY-
ROE-56.0%
EPS YoY-
ROA-22.8%
GROSS33
OP5
NET-42
[VALUATION]
P/E TTM-1.12
P/E FWD6.60
SECTOR PE20.54
INDUSTRY PE19.83
P/B0.77
P/FCF-
EV/EBITDA-3.95
EV/EBIT-
PEG1.01
FCF YIELD-
RISK
INT COV-
D/E130.96
ALTMAN Z-
CURR RATIO2.32
ND/EBITDA-
BETA0.54
Company news
FAQ
- What is LOPJLB’s current signal on PRGO?
- LOPJLB’s latest quantitative signal on Perrigo Company plc (PRGO) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is PRGO in?
- Perrigo Company plc (PRGO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Perrigo Company plc (PRGO) do?
- Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and o…